Ferring Deutschland: Presseaussendungen

Tuesday, June 01, 2010

Extension study with FIRMAGON^® (degarelix) showed continued benefits for prostate cancer patients beyond one year

|Read Press Release|

Monday, May 10, 2010

Ferring acquires LYSTEDA™ from Xanodyne Pharmaceuticals, Inc.

|Read Press Release|

Monday, April 19, 2010

Consider the "whole-man" when treating prostate cancer

|Read Press Release|

Monday, April 19, 2010

Wake Up to Nocturia - Studies Reinforce Serious Associated Risk of Nocturia

|Read Press Release|

Thursday, April 01, 2010

Xanodyne and Ferring announce co-promote for ZIPSOR™

|Read Press Release|